Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

Alok A. Khorana, MD, Jeffrey S Berger, MD, Philip S Wells, MD, Roger Seheult, MD, Veronica Ashton, MPH, François Laliberté, MA, Concetta Crivera, PharmD, MPH, Dominique Lejeune, MA, Jeff Schein, DrPH, MPH, Peter Wildgoose, PhD, Patrick Lefebvre, MA, Scott Kaatz, DO, MSc

Blood (2016) 128 (22): 144.

https://doi.org/10.1182/blood.V128.22.144.144

Published: 2016

Journal Articles

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Kristen M Scheitler, Post-Sophomore Fellow, Emily A Coberly, MD, A. Mosharraf Hossain, MD, Richard D Hammer, MD

Blood (2016) 128 (22): 4989.

https://doi.org/10.1182/blood.V128.22.4989.4989

Published: 2016

Journal Articles

Evaluation of Inpatient Thrombophilia Pathway

Emmanuel Emmanuel Isang, MD, Jonathan Dewald, MD, Mark Rasnake, MD, Robert E Heidel, PhD

Blood (2016) 128 (22): 4741.

https://doi.org/10.1182/blood.V128.22.4741.4741

Published: 2016

Journal Articles

Thrombophilia Testing in Hospitalized Children: Waste Not, Want Not?

Arash Mahajerin, MD, Terry Vik, MD, Rakesh P Mehta, MD, Mark Heiny, MD, PhD

Blood (2012) 120 (21): 1150.

https://doi.org/10.1182/blood.V120.21.1150.1150

Published: 2012

Journal Articles

Risk Factors for Thrombosis and the Beneficial Effect of Aspirin in Patients with Antiphospholipid Antibodies (aPL).

K. E. Hansen, MD, H. L. Kramm, D. Boh, C. B. Bell, S. Perry, MD, A. Potti, MD, T. L. Ortel, MD, PhD.

Blood (2004) 104 (11): 279.

https://doi.org/10.1182/blood.V104.11.279.279

Published: 2004

Journal Articles

Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction

Alexander P. Reiner, Susan R. Heckbert, Hans L. Vos, Robert A. S. Ariëns, Rozenn N. Lemaitre, Nicholas L. Smith, Thomas Lumley, Thomas D. Rea, Lucia A. Hindorff, Gina D. Schellenbaum, Frits R. Rosendaal, David S. Siscovick, Bruce M. Psaty

Blood (2003) 102 (1): 25–30.

https://doi.org/10.1182/blood-2002-07-2308

Published: 2003

NARROW

Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Evaluation of Inpatient Thrombophilia Pathway

Thrombophilia Testing in Hospitalized Children: Waste Not, Want Not?

Risk Factors for Thrombosis and the Beneficial Effect of Aspirin in Patients with Antiphospholipid Antibodies (aPL).

Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction

Email alerts

ASH Publications

American Society of Hematology

Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Evaluation of Inpatient Thrombophilia Pathway

Thrombophilia Testing in Hospitalized Children: Waste Not, Want Not?

Risk Factors for Thrombosis and the Beneficial Effect of Aspirin in Patients with Antiphospholipid Antibodies (aPL).

Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only